The use of acute, short-term residential care for opioid use disorder has grown rapidly, with
policy makers advocating to increase the availability of “treatment beds.” However, there are�…

Substance use disorders (SUDs) have an enormous impact on public health. With classic
psychedelic-assisted therapies showing initial promise in treating multiple SUDs, it is�…

Abstract 3D spheroids have emerged as powerful drug discovery tools given their high-
throughput screening (HTS) compatibility. Here, we describe a method for generating�…

Introduction Opioid-involved overdose deaths continue to surge in many communities,
despite numerous evidence-based practices (EBPs) that exist to prevent them. The HEALing�…

Objective Emergency department‐initiated buprenorphine (BUP) for opioid use disorder is
an evidence‐based practice, but limited data exist on BUP initiation practices in real‐world�…

Cross-sectional research has demonstrated the overrepresentation of gender dysphoria in
children and adults with autism spectrum disorder. However, the predictors and underlying�…

Background Impaired behavioral inhibition is a critical factor in drug addiction and relapse.
Repetitive transcranial magnetic stimulation (rTMS) reduces the craving of heroin-addicted�…

Background: Heart rate variability (HRV) is an indicator of autonomic abnormalities.
However, little is known about the role of HRV related to substance use behavior and the�…

Opioid use disorder is a leading cause of morbidity and mortality in the United States.
Increasing pre-clinical and clinical evidence demonstrates sex differences in opioid use and�…

Background Excessive consumption of opioids is associated with impaired metabolic
function including increased body mass index (BMI). Opioid antagonist naltrexone (NTX) is�…